-
1دورية أكاديمية
المؤلفون: Thomas Decker, Friedrich Overkamp, Siegfried Rösel, Arnd Nusch, Thomas Göhler, Martin Indorf, Jörg Sahlmann, Tanja Trarbach
المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
مصطلحات موضوعية: Metastatic breast cancer, Paclitaxel, Sorafenib, Antineoplastic agents/chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12885-017-3492-1Test; https://doaj.org/toc/1471-2407Test
-
2دورية أكاديمية
المؤلفون: Hossein Niknahad, Helia Hosseini, Fatemeh Gozashtegan, Farzaneh Ebrahimi, Negar Azarpira, Narges Abdoli, Reza Heidari
المصدر: Trends in Pharmaceutical Sciences, Vol 3, Iss 2, Pp 113-122 (2017)
مصطلحات موضوعية: Antineoplastic agents, Chemotherapy, Drug-Induced Liver Injury (DILI), Glutathione, Hepatotoxicity, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
العلاقة: http://tips.sums.ac.ir/index.php/TiPS/article/view/123Test; https://doaj.org/toc/2423-3722Test; https://doaj.org/toc/2423-5652Test
-
3
المؤلفون: Vincenzo Adamo, Sabino De Placido, Luigi Cavanna, Evaristo Maiello, Sandro Barni, Francesca Galli, Claudio Vernieri, M. Nicolini, Massimo Aglietta, Sara Lonardi, Maria Di Bartolomeo, Laura Ferrari, Emiliano Tamburini, Azzurra Damiani, Maria Giulia Zampino, Rosario Vincenzo Iaffaioli, Francesco Leonardi, Gerardo Rosati, Katia Fiorella Dotti, F. Galli, Paolo Marchetti, Paolo Giordani, Giovanni Lo Re, Alberto Zaniboni, Roberto Labianca, Maria Antista, Tosca Investigators, A. Ciarlo, Maria Banzi, Lorenzo Pavesi, Paolo Bidoli, Giovanni Luca Frassineti, Maria Chiara Tronconi, S. Ferrario, Stefania Gori, Daris Ferrari, Marina Faedi, Mario Clerico, Angela Buonadonna, Saverio Cinieri
المساهمون: Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C., Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Di Bartolomeo, M., Vernieri, C, Galli, F, Ferrari, L, Marchetti, P, Lonardi, S, Maiello, E, Iaffaioli, R, Zampino, M, Zaniboni, A, De Placido, S, Banzi, M, Damiani, A, Ferrari, D, Rosati, G, Labianca, R, Bidoli, P, Frassineti, G, Nicolini, M, Pavesi, L, Tronconi, M, Buonadonna, A, Ferrario, S, Re, G, Adamo, V, Tamburini, E, Clerico, M, Giordani, P, Leonardi, F, Barni, S, Ciarlo, A, Cavanna, L, Gori, S, Cinieri, S, Faedi, M, Aglietta, M, Antista, M, Dotti, K, Di Bartolomeo, M
المصدر: The oncologist. 24(3)
مصطلحات موضوعية: Aged, Antineoplastic Agents, Chemotherapy, Adjuvant, Colonic Neoplasms, Diabetes Mellitus, Type 2, Female, Fluorouracil, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Oxaliplatin, Risk Factors, 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, endocrine system diseases, Colorectal cancer, colon cancer (CC), radical surgery, Antineoplastic Agents, 03 medical and health sciences, 0302 clinical medicine, Type 2 diabetes mellitus (T2DM), colon cancer (CC), metformin, radical surgery, TOSCA study, Risk Factors, Diabetes mellitus, Internal medicine, Gastrointestinal Cancer, medicine, Adjuvant therapy, Humans, Hypoglycemic Agents, Prospective cohort study, Cancer staging, business.industry, Hazard ratio, nutritional and metabolic diseases, Middle Aged, medicine.disease, Metformin, Oxaliplatin, Type 2 diabetes mellitus (T2DM), 030104 developmental biology, TOSCA study, colon cancer, Diabetes Mellitus, Type 2, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Colonic Neoplasms, Female, Fluorouracil, business, medicine.drug
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308446709ede8b7e79b1090fd38e7536Test
https://pubmed.ncbi.nlm.nih.gov/30606884Test -
4
المؤلفون: Arnd Nusch, Tanja Trarbach, Friedrich Overkamp, Siegfried Rösel, J. Sahlmann, Thomas Decker, Thomas Göhler, Martin Indorf
المصدر: BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)مصطلحات موضوعية: Sorafenib, Oncology, Niacinamide, Cancer Research, medicine.medical_specialty, Combination therapy, Paclitaxel, Receptor, ErbB-2, Phases of clinical research, Breast Neoplasms, lcsh:RC254-282, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, Clinical endpoint, Medicine, Humans, 030212 general & internal medicine, Progression-free survival, Neoplasm Metastasis, Aged, business.industry, Phenylurea Compounds, Antineoplastic agents/chemotherapy, Middle Aged, medicine.disease, Interim analysis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastatic breast cancer, Gene Expression Regulation, Neoplastic, Treatment Outcome, 030220 oncology & carcinogenesis, Female, business, medicine.drug, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b4b2f859d068b09151501363befea5Test
http://europepmc.org/articles/PMC5526236Test -
5